Title: HEAVY METALS AND HEAVY METAL ANTAGONISTS
1HEAVY METALS AND HEAVY METAL ANTAGONISTS
2INTRODUCTION
- Metals - major fraction of Periodic Table
- generally interpreted to include those metals
from periodic table groups IIA through VIA - Heavy metals are natural constituents of the
Earth's crust and are present in varying
concentrations in all ecosystems - Metals differ from other toxic substances in that
they are neither created nor destroyed by humans.
Therefore, they tend to accumulate in the soils,
seawater, freshwater, and sediments.
3- Metals are probably the oldest toxins known to
humans. Lead usage may have begun prior to 2000
BC in the smelting of silver. Arsenic was
obtained during the melting of copper and tin,
and an early use was for decoration in Egyptian
tombs/
4- The environmental metals of greatest concern are
lead, mercury, arsenic, and cadmium..
5- In the past lead paint was available for use in
homes, and lead pipes and/or lead solder. As a
result people can be exposed to lead on a daily
basis this exposure is a major pediatric concern
6- Mercury is a contaminant of our water ways.
Humans are exposed to mercury in the fish they
eat as well as in the amalgam fillings in their
teeth. - Arsenic is found naturally in high concentration
in drinking water in various parts of the world.
Cadmium has been classified as a known human
carcinogen.
7CHEMICAL AND PHYSICAL PROPERTIES
- CHEMICAL AND PHYSICAL PROPERTIES
- 1. Physical states - solids, liquids, gases
aerosols - 2. Elements - indestructible
- 3. Electrophyllic cations - react with ligands
reversible complexes molecular mimicry - 4. Oxidation States affects toxicity
- 5. Organometallic compounds differ from inorganic
- 6. Essential versus non-essential
8- Heavy metals (HM) exert their toxic effects by
combining with one or more reactive groups
(ligands) essential for normal physiological
functions. - Heavy metal antagonists (HMA) - chelating agents
are designed specifically to compete with these
groups for the metals, and thereby prevent or
reverse toxic effects and enhance excretion of
metals.
9- Nearly all organ systems are involved in heavy
metal toxicity however, the most commonly
involved organ systems include the CNS, PNS, GI,
hematopoietic, renal, and cardiovascular (CV). To
a lesser extent, lead toxicity involves the
musculoskeletal and reproductive systems. The
organ systems affected and the severity of the
toxicity vary with the particular heavy metal
involved, the age of the individual, and the
level of toxicity.
10chelation Treatment of Metal Poisoning
- Chelaters (Greek claw) bind directly with metal
ions to form stable complexes that remove the
metal from competition with the body's cells.
Because a chelated metal is water soluble, it
can be excreted readily by the kidney.
11- By definition, Chelation is the formation of a
metal ion complex in which the metal ion is
associated with a charged or uncharged electron
donor, referred to as a ligand. A chelate is a
cyclic complex formed between a metal and a
compound that contains two or more ligands
(binding sites). The most stable chelates are
those with a five or six membered ring.
12Ideal chelating agents
- Water soluble
- Resistant to biotransformation
- Able to reach sites of metal storage
- Capable of forming nontoxic complexes with toxic
metals - Be excreted from the body
- Have a low affinity for essential metals
13Dimercaprol - BAL (British Antilewisite)
- BAL clinically useful for treating acute and
chronic poisoning by organic or inorganic
arsenals and for protecting against
mercury-induced renal damage. Not effective in
treating mercury-induced neurological conditions
or CNS damage. Not useful to chelate cadmium
because it can partially dissociate in urine and
enhance renal damage. Also true for iron and
selenium.
14- Must be given parentally. BAL blood concentration
are best achieved and maintained by giving
repeated doses within the first 4 hours after
poisoning. Excessive large doses should be
avoided because of possible side effects. - Dosage of BAL is designed to assure the formation
of a 21 complex (2 molecules of BAL 1 molecule
of metal).
15Adverse effects
- Tachycardia, hypertension, anxiety, nausea,
vomiting, abdominal pain, headache, agitation,
salivation, lacrymation, - Dental and muscle pains
- Pain at the site of injection.
- Burning sensation of the lips, mouth, throat and
eyes, conjunctivitis,rhinorrhoea, tingling of the
hands and other extremities, a feeling of
constriction in the chest and throat, sweating of
the forehead and hands.
16Calcium Disodium Edetate CaNa2 - EDTA
- will chelate any metal that has a higher binding
affinity than Ca (lead, iron, zinc, manganese,
beryllium and copper) - CaNa2EDTA does not enter host cells but relies on
excretion of lead into blood from bone. Lead
chelates with EDTA to form a complex that is 107
x greater than that of the Ca complex. - Toxicity to EDTA partly restricts its usage.
After IV administration, severe proximal nephron
degeneration may occur. Other symptoms include
fever, nasal congestion, and dermatitis.
17Penicillamine
- Penicillamine is formed from hydrolysis of
penicillin. It forms tight chelates with copper,
lead, mercury, and zinc. - An advantage of this chelator is that it is well
absorbed from the GI tract after oral
administration. Penicillamine is often given for
long-term treatment of chronic metal poisoning,
after the patient has been removed from immediate
danger. (i.e. CaNa2EDTA - lead BAL - mercury).
Pen is not universally recognized as the
first-choice antidote. -
18- Added advantage of pen is that it facilitates
removal of methyl mercury and enhances urinary
mercury excretion after inhalation of mercury
vapor. - Pen may cause acute allergy-like reactions,
particularly in individuals who are allergic to
penicillin must be carefully given to those
individuals.
19Succimer
- Succimer is chemically similar to dimercaprol
(BAL) but is more water soluble, has a high
therapeutic index, and is absorbed well from the
GI tract. (It is given orally). It produces a
lead diuresis comparable to that of CaNa2-EDTA
and reverses the biochemical toxicity of lead, as
indicated by normalization of circulatory
delta-aminolevulinic acid dehydratase (an enzyme
necessary for heme synthesis). The most common
adverse effects include nausea, vomiting,
diarrhea and anorexia.
20Deferoxamine
- Deferoxamine possesses high affinity for both
ferrous and ferric iron. It is given
parenterally, since less than 15 is absorbed
from the GI tract Toxicity - includes allergy
reactions related to histamine release. Pain at
the site of injection, rash, itching,
anaphylactic reactions, hypotension, tachycardia.
21Lead Toxicity
An estimated 1.7 million children are currently
affected by lead toxicity in United States, and
almost 900,000 of all children affected are under
the age of six. This statistic is very important
because the symptoms of lead poisoning in
children are strikingly similar to several
psychiatric "diseases" that are on the rise in
the U.S. Children with high lead levels can
exhibit lower IQ scores, learning disabilities,
hyperactivity , aggressive or disruptive
behavior, and difficulty maintaining attention. A
child exhibiting this type of behavior today
would likely be sent to a doctor's office,
diagnosed with attention deficit disorder, and
promptly started on Ritalin or other psychoactive
drugs.
Needleman HL ,1990
Lead levels and Hyperactivity
22Sources of Lead - environmental
- 1. Combustion of tetramethyl in gasoline
- 2. Persistent lead-based paint (children with
Pica) - 3. Improperly glazed earthenware
- 4. Lead piping (acid rain)
- 5. Solder in food containers
- 6. Moonshine whiskey
- 7. Automobile battery casing
23Occupational
- 1. Smelters (air concentration may exceed
1000g/m3) - 2. Storage battery manufacture (50 total U.S.
consumption) - 3. Welding and cutting lead-painted structures
- 4. Automobile radiator repair
- 5. Production of lead-based paints (6 total U.S.
consumption) - 6. Frequent use of firearms
24LEAD Distribution
25Absorption
- Gastrointestinal Tract
- 8 absorbed (adult)
- 50 absorbed (children)
- Ca, Fe decrease absorption
- Respiratory Tract - Particle size
- Chemical form
- Skin - Does occur at high exposures
26(No Transcript)
27(No Transcript)
28(No Transcript)
29(No Transcript)
30(No Transcript)